$Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease fragmin in unstable coronary artery disease study (FRIC)$

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease fragmin in unstable coronary artery disease study (FRIC)

Low-molecular-weight heparin has a number of pharmacological and pharmacokinetic advantages over unfractionated heparin that make it potentially suitable, when used in combination with aspirin, for the treatment of unstable coronary artery disease. Patients with unstable angina or non-Q-wave myocard...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 1997-07, Vol.96 (1), p.61-68
Hauptverfasser:	KLEIN, W, BUCHWALD, A, HILLIS, S. E, MONRAD, S, SANZ, G, TURPIE, A. G. G, VAN DER MEER, J, OLAISSON, E, UNDELAND, S, LUDWIG, K
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Angina, Unstable - drug therapy Anticoagulants - therapeutic use Aspirin - administration & dosage Biological and medical sciences Blood Coagulation Tests Blood. Blood coagulation. Reticuloendothelial system Dalteparin - therapeutic use Double-Blind Method Drug Administration Schedule Drug Therapy, Combination Female Heparin - therapeutic use Humans Injections, Intravenous Injections, Subcutaneous Male Medical sciences Middle Aged Myocardial Infarction - drug therapy Patient Compliance Pharmacology. Drug treatments Prospective Studies Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!